Fig. 6From: ZBTB7A, a potential biomarker for prognosis and immune infiltrates, inhibits progression of endometrial cancer based on bioinformatics analysis and experimentsCorrelation of ZBTB7A expression and the marker genes of infiltrating immune cells in UCEC (TIMER). The scatter plots showed correlation between ZBTB7A expression and the gene markers of (a) CD8+ T cell (CD8A); (b) T cell (general) (CD3D, CD3E, and CD2); (c) B cell (CD79A); (d) TAM (CD68); (e) Th17 (STAT3); (f) Neutrophils (CD66b, CD11b, and CCR7); (g, h) Dendritic cell (HLA-DPB1, HLA-DQB1, HLA-DRA, HLA-DPA1, BDCA1, BDCA4 and CD11c); (i) Th1 (STAT4, T-bet, and CD4); (j) Th 2 (GATA3, STAT6, STAT5A, and CCR4); (k) and Treg (TGFB1, STAT5B, and CCR8) in UCEC samples (n = 545)Back to article page